Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China

Journal of Diabetes

Volumn 7, Issue 3, 2015, Pages 307-314

  Wan, Qiang ^a,b   Xu, Yanying ^a   Dong, Erdan ^a  

^a NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; National Natural Science Foundation of China funding profile

Indexed keywords

BIOLOGICAL MARKER;

CHINA; CHINESE HERB; DATA ANALYSIS; DIABETIC NEPHROPATHY; FUNDING; HUMAN; NATURAL SCIENCE; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRADITIONAL MEDICINE; DIABETIC NEPHROPATHIES; FINANCIAL MANAGEMENT; MEDICAL RESEARCH; NON PROFIT ORGANIZATION; STATISTICS;

BIOMEDICAL RESEARCH; CHINA; DIABETIC NEPHROPATHIES; FOUNDATIONS; HUMANS; RESEARCH SUPPORT AS TOPIC; STATISTICS AS TOPIC;

EID: 84928210058     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12265     Document Type: Review

References (53)

1. Collins AJ, Kasiske B, Herzog C etal. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis. 2007; 49:A6-7, S1-296.
2. Yang W, Lu J, Weng J etal. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362: 1090-1101.
3. Cha DR, Han JY, Su DM etal. Peroxisome proliferator-activated receptor-alpha deficiency protects aged mice from insulin resistance induced by high-fat diet. Am J Nephrol. 2007; 27: 479-482.
4. Cha DR, Zhang X, Zhang Y etal. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. Diabetes. 2007; 56: 2036-2045.
5. Zhou Y, Kong X, Zhao P etal. Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury. Kidney Int. 2011; 79: 1302-1311.
6. Hao J, Zhu L, Zhao S, Liu S, Liu Q, Duan H. PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells. Exp Cell Res. 2011; 317: 1629-1639.
7. Liu W, Hao J, Zhu L etal. Phospho-GSK-3β is involved in the high-glucose-mediated lipid deposition in renal tubular cells in diabetes. Int J Biochem Cell Biol. 2013; 45: 2066-2075.
8. Zhang D, Yang H, Kong X etal. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am J Physiol Endocrinol Metab. 2011; 300: E287-295.
9. Xiao L, Zhu X, Yang S etal. Rap1 ameliorates renal tubular injury in diabetic nephropathy. Diabetes. 2014; 63: 1366-1380.
10. Xue H, Yuan P, Ni J etal. H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation. PLoS One. 2013; 8: e74366.
11. Yang L, Liang M, Zhou Q etal. Advanced oxidation protein products decrease expression of nephrin and podocin in podocytes via ROS-dependent activation of p38 MAPK. Sci China Life Sci. 2010; 53: 68-77.
12. Qi JS, Li YN, Zhang BS, Niu T, Liang JH. Peroxynitrite mediates high glucose-induced osteoblast apoptosis. J Endocrinol Invest. 2008; 31: 314-320.
13. Wang F, Tian F, Whitman SA etal. Regulation of transforming growth factor β1-dependent aldose reductase expression by the Nrf2 signal pathway in human mesangial cells. Eur J Cell Biol. 2012; 91: 774-781.
14. Guoguo S, Akaike T, Tao J, Qi C, Nong Z, Hui L. HGF-mediated inhibition of oxidative stress by 8-nitro-cGMP in high glucose-treated rat mesangial cells. Free Radic Res. 2012; 46: 1238-1248.
15. Hui L, Hong Y, Jingjing Z, Yuan H, Qi C, Nong Z. HGF suppresses high glucose-mediated oxidative stress in mesangial cells by activation of PKG and inhibition of PKA. Free Radic Biol Med. 2010; 49: 467-473.
16. Zoja C, Benigni A, Remuzzi G. The Nrf2 pathway in the progression of renal disease. Nephrol Dial Transplant. 2014; 29: i19-i24.
17. Cui W, Bai Y, Miao X etal. Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation. Oxid Med Cell Longev. 2012; 2012: 821936.
18. Cui W, Bai Y, Luo P, Miao L, Cai L. Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury. Oxid Med Cell Longev. 2013; 2013: 306073.
19. Luo ZF, Qi W, Feng B etal. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome. Life Sci. 2011; 88: 512-520.
20. Wang X, Chen H, Zhang M, Liu Z. Roles of mast cells and monocyte chemoattractant protein-1 in the renal injury of obesity-related glomerulopathy. Am J Med Sci. 2013; 346: 295-301.
21. Chen K, Zhang J, Zhang W etal. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy. Int J Biochem Cell Biol. 2013; 45: 932-943.
22. Du P, Fan B, Han H etal. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int. 2013; 84: 265-276.
23. Wang J, Gao Y, Ma M etal. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochem Biophys. 2013; 67: 537-546.
24. Mu J, Pang Q, Guo YH etal. Functional implications of microRNA-215 in TGF-β1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1. PLoS One 2013; 8: e58622.
25. Zhang Z, Luo X, Ding S etal. MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. FEBS Lett. 2012; 586: 20-26.
26. Zhuang L, Li M, Yu C etal. The Leu72Met polymorphism of the GHRL gene prevents the development of diabetic nephropathy in Chinese patients with type 2 diabetes mellitus. Mol Cell Biochem. 2014; 387: 19-25.
27. Liu L, Zheng T, Wang F etal. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Care. 2010; 33: 144-149.
28. Liu L, Zheng T, Wang N etal. The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes. Mol Cell Biochem. 2009; 322: 87-91.
29. Liu L, Xiang K, Zheng T, Zhang R, Li M, Li J. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Mol Cell Biochem. 2003; 254: 353-358.
30. Zheng M, Lv LL, Ni J etal. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS One. 2011; 6: e20431.
31. Li M, Wang X, Aa J etal. GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy. Am J Physiol Renal Physiol. 2013; 304:F1317-1324.
32. Jiang H, Guan G, Zhang R etal. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev. 2009; 25: 232-241.
33. Jiang H, Guan G, Zhang R etal. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy. Nephrology (Carlton). 2009; 14: 332-337.
34. Lanni A1, Moreno M, Lombardi A etal. 3, 5-diiodo-l-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB J. 2005; 19: 1552-1554.
35. Shang G, Gao P, Zhao Z etal. 3, 5-Diiodo-l-thyronine ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats. Biochim Biophys Acta. 2013; 1832: 674-684.
36. Li Y, Zhao M, Li B, Qi J. Dynamic localization and functional implications of C-peptide might for suppression of iNOS in high glucose-stimulated rat mesangial cells. Mol Cell Endocrinol. 2013; 381: 255-260.
37. Xing X, Zhang C, Shao M etal. Low-dose radiation activates Akt and Nrf2 in the kidney of diabetic mice: a potential mechanism to prevent diabetic nephropathy. Oxid Med Cell Longev. 2012; 2012: 291087.
38. Chen X, Qiu Z, Yang S etal. Effectiveness and safety of a therapeutic vaccine against angiotensin II receptor type 1 in hypertensive animals. Hypertension 2013; 61: 408-416.
39. Qiu Z, Chen X, Zhou Y etal. Therapeutic vaccines against human and rat renin in spontaneously hypertensive rats. PLoS One 2013; 8: e66420.
40. Wang S, Li Y, Zhao J, Zhang J, Huang Y. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Biol Blood Marrow Transplant. 2013; 19: 538-546.
41. Zhang L, Li K, Liu X etal. Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats. Stem Cells Dev. 2013; 22: 3074-3086.
42. Li D, Wang N, Zhang L etal. Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor. Stem Cell Res Ther. 2013; 4: 103.
43. Zheng JM, Zhu JM, Li LS, Liu ZH. Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway. Br J Pharmacol. 2008; 153: 1456-1464.
44. Gao Q, Shen W, Qin W etal. Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol Dial Transplant. 2010; 25: 3539-3547.
45. Li X, Liu W, Wang Q etal. Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose. Mol Cell Endocrinol. 2009; 307: 157-162.
46. Lan T, Liu W, Xie X etal. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells. Mol Endocrinol. 2011; 25: 2094-2105.
47. Lan T, Liu W, Xie X etal. Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway. Eur J Pharmacol. 2012; 697: 165-172.
48. Huang J, Huang K, Lan T etal. Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway. Mol Cell Endocrinol. 2013; 365: 231-240.
49. Xu H, Shen J, Liu H, Shi Y, Li L, Wei M. Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress. Can J Physiol Pharmacol. 2006; 84: 1267-1273.
50. Qiu W, Zhou Y, Jiang L etal. Genipin inhibits mitochondrial uncoupling protein 2 expression and ameliorates podocyte injury in diabetic mice. PLoS One 2012; 7: e41391.
51. Wen X, Zeng Y, Liu L etal. Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c. J Ethnopharmacol. 2012; 142: 144-150.
52. Zhang H, Zhao T, Gong Y etal. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics. J Ethnopharmacol. 2014; 151: 556-564.
53. Zhang H, Li P, Burczynski FJ etal. Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula). Evid Based Complement Alternat Med. 2011; 2011: 613737.